Intravenous fluid therapy in hospitalized adult dengue patients without shock: Impact on subsequent severe dengue and potential adverse effects
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Baihui Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore City, Singapore. Hauptthemen laut MEDLINE: Fluid Therapy, Administration, Intravenous, Hospitalization, Severe Dengue. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: National Medical Research Council.
Abstract (Originalsprache)
There is a lack of evidence on the optimal administration of intravenous (IV) fluids in hospitalized adult dengue patients without compensated and hypotensive shock. This study utilized a well‐established cohort of dengue patients to compare risks of progressing to severe dengue (SD) over time for patients who were administered IV fluid versus others who were not. We included adult patients ( n = 4781) who were hospitalized for dengue infection from 2005 to 2008. Cases were patients who developed SD ( n = 689) and controls were patients who did not up until discharge ( n = 4092). We estimated the hazard ratios (HRs) and risk of SD over time between groups administered different volumes of IV fluids versus the no IV fluid comparison group using Cox models with time‐dependent covariates. The doubly‐robust estimation approach was used to control for the propensity of fluid administration given clinical characteristics of patients. Subgroup analyses by age, sex, and dengue warning signs before IV fluid administration were conducted. High (>2000 mL/day) IV fluids volume was associated with a higher risk of development of SD for those who had warning signs (HR: 1.77 [1.05–2.97], p : 0.0713) and for those below 55 years old (HR: 1.53 [1.04–2.25], p : 0.0713). Low (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore City, Singapore.
- Department of Infectious Diseases, National Centre for Infectious Diseases, Singapore City, Singapore.
- Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore City, Singapore.
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore City, Singapore.
ORCID-Profile: Baihui Xu
Förderung
- National Medical Research Council
Zitieren
APA
Xu, B., Tewari, P., Thein, T. L., Sin, L. Y., Lye, D. C. B., Chia, P. Y., & Lim, J. T. (2024). Intravenous fluid therapy in hospitalized adult dengue patients without shock: Impact on subsequent severe dengue and potential adverse effects. Journal of Medical Virology. https://doi.org/10.1002/jmv.29726
Vancouver
Xu B, Tewari P, Thein TL, Sin LY, Lye DCB, Chia PY, et al. Intravenous fluid therapy in hospitalized adult dengue patients without shock: Impact on subsequent severe dengue and potential adverse effects. Journal of Medical Virology. 2024. doi:10.1002/jmv.29726
BibTeX
@article{Xu2024,
author = {Xu, Baihui and Tewari, Pranav and Thein, Tun Linn and Sin, Leo Yee and Lye, David Chien Boon and Chia, Po Ying and Lim, Jue Tao},
title = {Intravenous fluid therapy in hospitalized adult dengue patients without shock: Impact on subsequent severe dengue and potential adverse effects},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29726}
}
EUVIMED